The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...
The administration of U.S. President Donald Trump has instructed federal health agencies to pause all external communications ...
The Food and Drug Administration has approved Johnson & Johnson's nasal spray as a standalone treatment for severe forms of ...
The U.S. Food and Drug Administration on Tuesday approved the first nasal spray that will help with treating major depressive ...
The agencies are charged with making decisions that touch the lives of every American and are the source of crucial ...
Last year, Michigan started its “Take Control of your Birth Control” program, offering free birth control to residents, ...
The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its ...
The Biden administration's eleventh-hour proposal to lower nicotine concentrations in cigarettes has led some Floridians to ...
On Tuesday, the U.S. Food and Drug Administration (FDA) placed a clinical hold on Atara Biotherapeutics, Inc.’s (NASDAQ:ATRA) ...
Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...
The FDA says vaping companies are improperly gaming the court system, filing claims in an appeals court they think will be sympathetic to them.
On his first day in office, President Donald Trump announced plans to pull America from the Paris Agreement and expand the production of oil, both campaign promises.